Mode
Home
Research
Clinical Trials Drug Pipeline Weekly Digests
Reference
Conditions Medications
Community
Questions
Text Size
Log in / Sign up
N/A Completed N=42 Prevention

The TARANG Intervention

Feasibility · Acceptability · Family Planning · Unintended Pregnancy
Source: ClinicalTrials.gov NCT06320964 ↗
Enrolled (actual)
42
Serious AEs
0.0%
Results posted
Feb 2025
Primary outcomePrimary: Feasibility of the Intervention — 28 Participants

Summary

The mixed methods pilot study aims to evaluate the acceptability, feasibility, and implementation challenges of the TARANG intervention in villages in rural/tribal Rajasthan to inform the study design and operational details for a larger cluster-randomized controlled trial.

Outcome Measures

OutcomeResultp-value
PRIMARY
Feasibility of the Intervention		 28 —
PRIMARY
Acceptability		 34 —
PRIMARY
Usefulness		 35 —

Eligibility Criteria

Inclusion Criteria

Newly married women:

  • Age 18-25 years at the time of wedding
  • Does not plan to move out of the area for the period of the intervention
  • Mother-in-law has agreed to support daughter-in-law's participation in the study
  • Mother-in-law and husband are eligible for the study participation

Husbands:

  • 18 years or more at the time of the wedding
  • Does not plan to move out of the village during period of the intervention
  • Mother and wife are eligible for study participation

Mothers-in-law:

  • Has a daughter-in-law who is eligible and willing to participate in the study
  • Provides individual consent to participate in the study
  • Assents for daughter-in-law to participate in the study
  • Does not plan to move out of the village during period of the intervention
  • The son and the daughter-in-law are eligible for study participation

Exclusion Criteria

Newly married women:

  • Wanting to have a child in the next 12 months at the time of baseline
  • Cognitive ability to participate in surveys
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT06320964). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.

Back to search